Citation Impact
Citing Papers
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
Computational Radiomics System to Decode the Radiographic Phenotype
2017 Standout
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
2014
18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
2011
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Reproducibility of radiomics for deciphering tumor phenotype with imaging
2016
Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
2007
Gastric cancer
2016 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Improving the Lung Cancer Resection Rate in the US Department of Veterans Affairs Health System
2006
Molecular imaging in drug development
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
PET in the management of locally advanced and metastatic NSCLC
2015
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
2006
The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer
2016
Discordant Response to Chemotherapy Detected by PET Scanning
2002
Efficacy of 2-halogen substituted d-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”
2006
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: A prospective study
2006
Beyond the Genome
2001
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project
2008
Applications and limitations of radiomics
2016
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
2003
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Characterization of PET/CT images using texture analysis: the past, the present… any future?
2016
Can small animal imaging accelerate drug development?
2002
Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
2008
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
2007
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
2010
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
2012
CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer
2016
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Sarcoidosis
2013 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma
2010
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Advances in FDG PET Probes in Surgical Oncology
2002
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Robust Radiomics Feature Quantification Using Semiautomatic Volumetric Segmentation
2014
F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy
2005
Clinical role of positron emission tomography in oncology
2001
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Quantitative Analysis of 18F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
2016
Clinical molecular imaging with positron emission tomography
2006
In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging
2015
Guidelines for the management of oesophageal and gastric cancer
2011
Promise and pitfalls of quantitative imaging in oncology clinical trials
2012
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
2015
Quantitative assessment of dynamic PET imaging data in cancer imaging
2012
18F-FDG PET/CT Role in Staging of Gastric Carcinomas
2015
Microenvironmental regulation of metastasis
2008 Standout
Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas
2008
Molecular Imaging Applications in Nanomedicine
2004
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Measuring Computed Tomography Scanner Variability of Radiomics Features
2015
Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells
2015
Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives
2008
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
2015
Importance of Quantification for the Analysis of PET Data in Oncology: Review of Current Methods and Trends for the Future
2011
Standards for PET Image Acquisition and Quantitative Data Analysis
2009
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Overview of early response assessment in lymphoma with FDG-PET
2007
Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods
2003
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
2008
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Artificial intelligence in radiology
2018 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Neoadjuvant Chemotherapy Generates a Significant Tumor Response in Resectable Pancreatic Cancer Without Increasing Morbidity
2008
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Pulmonary actinomycosis
2003 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Gene therapy imaging in patients for oncological applications
2005
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma
2015
Molecular imaging of gene expression and protein function in vivo with PET and SPECT
2002
A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment
2008
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell–Renal-Cell-Carcinoma: Proof-of-Concept Study
2017
Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer
2004
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors
2006
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
The clinical impact of integrated FDG PET–CT on management decisions in patients with lung cancer
2008
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
2012
[18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer
2005
Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography
2008
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
2007
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
2005
Positron Emission Tomography As an Imaging Biomarker
2006
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
2007
Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.
2004
Early variation of FDG-PET radiomics features in NSCLC is related to overall survival - the “delta radiomics” concept
2016
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures
2016
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Preoperative Assessment of Cytologically Indeterminate Thyroid Nodules
2007
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Defining the biological basis of radiomic phenotypes in lung cancer
2017
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
2006
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
2004
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of C. Hoekstra being referenced
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies
1999
Thoracic Actinomycosis Imaging With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
1999
FDG-PET has no definite role in preoperative imaging in gastric cancer
2009
The value of [18F]fluoro-2-deoxy-?-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
2003
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
2008
Partial volume correction strategies for quantitative FDG PET in oncology
2010
Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial
2004
How should we analyse FDG PET studies for monitoring tumour response?
2006
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
2013
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.
2002
Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer
2005
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.
2002